Apr 30, 2024, 07:06 | Insight

Myeloma Paper of the Day, April 29th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…

Apr 28, 2024, 16:18 | Societies

OncoDaily Leukemia Conference: Day 2

"The best specialists in the field of hematology and numerous interesting and informative reports. The…

Apr 27, 2024, 10:58 | Blog

The King will soon return to public duties after recovering from cancer treatment

The Royal Family shared the latest news about King Charles' recovery on their X page:…

Apr 27, 2024, 07:08 | Blog

Oncologist Near Me - Eric Small: Prominent Prostate Cancer Specialist

Oncologist Near Me: Eric Small Special initiative by OncoDaily Welcome to OncoDaily's special section "Oncologist…

Apr 26, 2024, 17:42 | Insight

New Paper Alert! The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms

The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms Authors:…

Apr 25, 2024, 19:48 | Insight

New Paper Alert! The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with Cancer

The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with…

Apr 25, 2024, 14:18 | Career

Gevorg Tamamyan: It is an extreme honor being elected as the President-Elect of SIOP Asia

Gevorg Tamamyan shared on LinkedIn: "It is an extreme honor being elected as the President-Elect of…

Apr 25, 2024, 00:51 | Insight

New Paper Alert! Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma

Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma Authors: T. Powles,…

Apr 24, 2024, 17:24 | Blog

U.S. FDA approved the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma - Day One Biopharmaceuticals

Day One Biopharmaceuticals shared a post on LinkedIn: "Breaking News: Today, we are thrilled to share…

Apr 24, 2024, 12:52 | Blog

Monica Bertagnolli: NIH will increase annual pay levels for predoctoral and postdoctoral scholars who are recipients of the Ruth L. Kirschstein National Research Service Awards (NRSA)

Apr 24, 2024, 09:13 | Drugs

FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer

FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…

Apr 23, 2024, 18:57 | Insight

New Paper Alert! Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of the Literature

Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of…

Apr 22, 2024, 19:23 | Insight

New Paper Alert! A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation

A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners…

Apr 22, 2024, 11:59 | Positive

Yvonne Award 2024 by OncoDaily

The Yvonne Award by OncoDaily, symbolizing the strength and longevity of the yew tree, honors…

Apr 22, 2024, 11:11 | Insight

New Paper Alert! Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy

Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated…

Apr 21, 2024, 08:54 | Insight

Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe

Rana McKay won the 2024 Christopher G. Wood Rising Star Award at IKCS Europe, which…

Apr 21, 2024, 08:05 | Insight

New Paper Alert! Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer

Exploring the Potential of 18F-BMS-986229 PET for Noninvasive Assessment of PD-L1 Expression in Gastroesophageal Cancer…

Apr 21, 2024, 06:16 | Dialogues

Oncodaily Dialogues #8 Mikkael Sekeres/ Hosted by Roupen Odabashian

In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…

Apr 20, 2024, 06:18 | Insight

New Paper Alert! Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer

Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer Authors: David Planchard, Rachel E. Sanborn,…

Apr 19, 2024, 16:30 | Insight

New Paper Alert! Outcomes of high-risk individuals undergoing pancreatic cancer surveillance

Effective Surveillance Strategies for High-Risk Pancreatic Cancer Individuals Authors: Aleksander M. Bogdanski, Jeanin E. van…

Apr 18, 2024, 16:36 | Insight

New Paper Alert! Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy

Understanding the Effects of Post-irAE Treatments With Immunosuppressant Agents in Cancer Immunotherapy Authors: Pierre-Louis Cariou,…

Apr 18, 2024, 11:57 | Insight

New Paper Alert! The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based on Microsatellite Instability Status

The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based…

Apr 17, 2024, 13:11 | Insight

New Paper Alert! Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal Cancer: A Real-World Analysis

New Paper Alert: Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal…

Apr 13, 2024, 11:51 | Dialogues

OncoDaily Walk and Talk with Dinesh Pendharkar, Hosted by Tatev Margaryan

Welcome back to Walk and Talk on OncoDaily! Our guest for today is Dinesh Pendharkar.…

Apr 13, 2024, 03:43 | Blog

FDA ODAC voted 12-0. Historic victory in multiple myeloma

On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…

Apr 12, 2024, 03:19 | Dialogues

OncoInfluencers: Dialogue with Pasi Jänne, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In…

Apr 8, 2024, 22:37 | Insight

Key Message Highlights from Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous…

Apr 6, 2024, 16:25 | Insight

New Article Alert! FOLFIRI plus durvalumab with or without tremelimumab in advanced gastric or GEJ adenocarcinoma

FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal…

Apr 6, 2024, 16:19 | Insight

Nivolumab with chemotherapy to use before surgery in patients with pancreatic cancer - UCLA Health Jonsson Comprehensive Cancer Center

A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for…

Mar 31, 2024, 11:21 | Positive

Gevorg Tamamyan: Get your best dresses and prepare your luxury shoes for The Biggest and Amazing Party of the Year

Gevorg Tamamyan, the Editor-in-chief of OncoDaily, shared on X/Twitter: "It is an extreme honor and pleasure…

Mar 30, 2024, 11:05 | Dialogues

The Comfort Corner #1: Dialogue with Matti Aapro, hosted by Martin Harutyunyan

Welcome to "The Comfort Corner" - a palliative care series that brings together medical professionals…

Mar 28, 2024, 19:11 | Dialogues

OncoInfluencers: Dialogue with Douglas Flora, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In…

Mar 27, 2024, 11:45 | Societies

Rob Pieters is the newly elected President of International Society of Paediatric Oncology – SIOP

“If cure rates for ALL can go from 0% to 85% in 40 years we…

Mar 26, 2024, 14:54 | Dialogues

Cancer and Crisis Talks with Jemma Arakelyan #3 - Dr. Nazik Hammad

We are thrilled to unveil the next captivating episode of our enlightening series, "Cancer and…

Mar 24, 2024, 02:12 | Opinion

OncoDaily is happy to become the official partner of the International Society of Paediatric Oncology (SIOP)

It is with great honor and immense pleasure that we announce the official partnership between…

Mar 23, 2024, 15:29 | Dialogues

OncoDaily Dialogues #7: Aparna Parikh / Hosted by Roupen Odabashian

In our ongoing series called “OncoDaily Dialogues,”we consistently feature prominent individuals in the field of…

Mar 22, 2024, 16:24 | Positive

Top 100 Xfluencers in Colorectal Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

As March, Colorectal Cancer Awareness Month, draws to its end, we're excited to announce our…

Mar 22, 2024, 15:57 | Dialogues

OncoInfluencers: Dialogue with Lillian L. Siu, hosted by Gevorg Tamamyan

Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In…

Mar 22, 2024, 02:24 | Positive

Lillian Siu Honored with the 2024 ASCO David Karnofsky Memorial Award

The American Society of Clinical Oncology (ASCO) has announced Dr. Lillian L. Siu, MD, FRCPC,…

Mar 20, 2024, 16:53 | Insight

Vincent Rajkumar: ODAC votes 11-0 to recommend approval of Cilta-Cel in patients with relapsed/refractory multiple myeloma in earlier stages

Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X/Twitter: "Breaking: ODAC votes…

Mar 16, 2024, 10:29 | Dialogues

OncoDaily Dialogues #6 – Navneet Singh / Hosted by Roupen Odabashian

In our ongoing series called "OncoDaily Dialogues," we consistently feature prominent individuals in the field…

Mar 15, 2024, 10:13 | Blog

AACR members have elected Lillian L. Siu as their 2024-2025 President-Elect

AACR shared a post on X: "AACR members have elected AACR Fellows Lillian L. Siu, MD,…

Mar 14, 2024, 18:42 | Dialogues

5 min Sarcoma Talk with Shushan Hovsepyan and Leo Kager

Welcome to the world of sarcoma with the first episode of '5 Min Sarcoma Talk'…

Mar 11, 2024, 20:55 | Stories

Tracey O'Brien: This international women's day threw me the best curveball yet, and it came from none other than my 14-year-old son

Tracey O'Brien, NSW Chief Cancer Officer, posted on LinkedIn: "This international women's day threw me the…

Mar 11, 2024, 03:24 | Career

Amer Zeidan was appointed as the inaugural Chief of the Division of Hematologic Malignancies at Yale Cancer Center

Yale Cancer Center shared on LinkedIn: "We are pleased to announce that Amer Zeidan was…

Mar 10, 2024, 21:03 | Blog

Vivek Subbiah: Research should be standard-of-care and standard-of-care should be research

Vivek Subbiah recently posted on LinkedIn: "Yes! “Research should be standard-of-care and standard-of-care should be research”!!!…

Mar 9, 2024, 19:24 | Blog

11 posts not to miss from International Women's Day 2024

International Women's Day is celebrated annually on March 8th. Below are featured some of the…

Mar 9, 2024, 18:49 | Societies

Global Summit on War and Cancer 2023: Julie Gralow's speech on the role of professional societies in supporting cancer care in conflict zones

The 1st Global Summit on War and Cancer took place on 14 - 16 December…

Mar 4, 2024, 01:54 | Dialogues

OncoDaily Walk and Talk with Enrique Soto, Hosted by Tatev Margaryan

Welcome back to Walk & Talk on OncoDaily! Our guest for today is Dr. Enrique…

Mar 2, 2024, 12:46 | Dialogues

OncoInfluencers: Dialogue with Julie Gralow, hosted by Gevorg Tamamyan

Join us for an exciting episode of “OncoInfluencers,” with our host Dr. Gevorg Tamamyan. In…

Mar 1, 2024, 18:29 | Insight

Tedros Adhanom Ghebreyesus: I recently saw a report of 40 people who needed dialysis dying in one state in Sudan, and this situation is not unique to Sudan.

Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, shared on X/Twitter: "Cancer, diabetes, heart…

Feb 28, 2024, 18:16 | Blog

Rebecca Shatsky: We need to do more to debunk this growing threat of total disinformation

Rebecca Shatsky shared a post on X/Twitter: "I had a patient recently with advanced stage…

Feb 26, 2024, 11:06 | Stories

Daniella T.: Even if we’re apart… I’ll always be with you

Daniella T. shared on LinkedIn: "If you’re reading this then it means I have died…

Feb 22, 2024, 18:13 | Blog

Jill Biden: I am excited to share the first major deliverable from our White House Initiative on Women’s Health Research

Jill Biden recently shared on X/Twitter: "Today, I am excited to share the first major…

Feb 19, 2024, 04:12 | Dialogues

OncoDaily Walk and Talk with Maite Gorostegui, Hosted by Tatev Margaryan

Welcome back to Walk & Talk on OncoDaily! Our guest for today is Dr. Maite…

Feb 14, 2024, 14:59 | Blog

Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL

Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…

Feb 11, 2024, 07:31 | Insight

Belén Garijo: I´m grateful to everyone across the scientific community who think and act like Einstein

Belén Garijo, Chair of the Executive Board and CEO of Merck, shared on LinkedIn: "There…

Feb 5, 2024, 03:55 | Dialogues

OncoInfluencers: Dialogue with Nagashree Seetharamu, hosted by Gevorg Tamamyan

Join us for an exciting episode of “OncoInfluencers,” with our host Dr. Gevorg Tamamyan. In…

Feb 5, 2024, 02:47 | Opinion

Piotr J. Wysocki: The Armenian Oncology Congress is an example of how oncology is developing extremely dynamically in this small but very ambitious country

Piotr J. Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University…

Feb 4, 2024, 11:12 | Blog

Rafael Grossi: Monumental steps in ensuring quality cancer care is accessible to all, regardless of geography

Rafael Grossi, Director General at the International Atomic Energy Agency (IAEA), shared on their LinkedIn:…

Feb 2, 2024, 12:35 | Blog

Ulrika Årehed Kågström: UICC has released its World Cancer Day 2024 Equity Report

Quoting Ulrika Årehed Kågström on LinkedIn: "Union for International Cancer Control (UICC) has released its World Cancer…

Jan 27, 2024, 07:20 | Blog

Richard Scolyer: Still no recurrence of my supposedly incurable glioblastoma!

Richard Scolyer, CoMedical Director at Melanoma Institute Australia and Surgical Pathologist at Royal Prince Alfred…

Jan 26, 2024, 17:17 | Societies

30 Posts Not To Miss From ASCO GI24

The ASCO Gastrointestinal Cancer Symposium (GI24) took place from the 18th to the 20th of…

Jan 26, 2024, 07:33 | Blog

María Natalia Gandur Quiroga: Fantastic article... One of the most anticipated!

María Natalia Gandur Quiroga posted on LinkedIn: "Fantastic article! One of the most anticipated! New…

Jan 25, 2024, 17:09 | Blog

Runcie Chidebe: This is one of my most important studies

Runcie Chidebe, Executive Director at Project PINK BLUE, recently posted on LinkedIn: "As a patient…

Jan 20, 2024, 14:14 | Drugs

Pashtoon Kasi: Are we on the verge of a new drug combo for colon or rectal cancer?

Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X: "🆕🗞️Just…

Jan 16, 2024, 07:31 | Blog

22 Tweets from JPM 2024 not to miss

The 42nd J.P. Morgan Annual Healthcare Conference took place from January 8th to January 11th,…

Jan 12, 2024, 07:07 | Dialogues

OncoDaily Dialogues #5 – Sarkis Meterissian / Hosted by Roupen Odabashian

In our ongoing series called "OncoDaily Dialogues," we consistently feature prominent individuals in the field…

Jan 9, 2024, 08:50 | Blog

Prominent cancer specialists and emerging leaders in the field of oncology join the Editorial Board of OncoDaily

OncoDaily welcomes world-renowned cancer specialists and emerging leaders in oncology. We are honored to have…

Jan 7, 2024, 04:24 | Stories

Ryan Brown: Cocktails for a Cure - Supporting Children like Julianna

Ryan Brown, Vice President at Goldman Sachs and Board Member at St. Baldrick’s Foundation, shared…

Jan 6, 2024, 13:13 | Positive

Gevorg Tamamyan: OncoDaily became one of the leading and one of the fastest growing media platforms in the oncology world

Gevorg Tamamyan, the Editor-in-chief of OncoDaily, shared on LinkedIn: "New Year report on OncoDaily :)…

Jan 5, 2024, 07:09 | Opinion

Why SOAR? Written by 2 physicians and a literary wizard from three different continents

By Ketan Kulkarni Why SOAR? Medicine is a noble and exceptionally rewarding profession. It…

Dec 31, 2023, 13:33 | Positive

100 Influential Celebrities in Oncology: The 2023 Edition

As we reach the final day of the year this December 31st, OncoDaily concludes the…

Dec 31, 2023, 11:35 | Positive

100 Influential Celebrities in Oncology: The 2023 Edition – Part 10

As we continue with Part 10 of OncoDaily's "100 Influential Celebrities in Oncology: The 2023…

Dec 30, 2023, 16:03 | Positive

100 Influential Celebrities in Oncology: The 2023 Edition – Part 9

In this ninth edition of OncoDaily's "100 Influential Celebrities in Oncology: The 2023 Edition," we…

Dec 26, 2023, 04:08 | Dialogues

OncoDaily Dialogues #4 - Therese Mulvey / Hosted by Roupen Odabashian

In our series "OncoDaily Dialogues," we continue to spotlight eminent figures in oncology, sharing their…

Dec 24, 2023, 12:49 | Opinion

Cancer research and treatment priorities for 2024: NCI's new director talks to cancer community

Dr. Kimryn Rathmell, the new Director of the US National Cancer Institute (NCI), asked on…

Dec 23, 2023, 18:15 | Positive

100 Influential Celebrities in Oncology: The 2023 Edition – Part 8

OncoDaily's "100 Influential Celebrities in Oncology: The 2023 Edition" continues with Part 8, showcasing a…

Dec 16, 2023, 17:09 | Positive

100 Influential Celebrities in Oncology: The 2023 Edition – Part 7

Welcome to Part 7 of OncoDaily's "100 Influential Celebrities in Oncology: The 2023 Edition." This…

Dec 16, 2023, 03:11 | Societies

A New Era in Oncology: Dr. Eric J. Small Elected as ASCO President Alongside Distinguished Board Members

American Society of Clinical Oncology (ASCO) shared on LinkedIn: "Congratulations to Eric J. Small, MD,…

Dec 15, 2023, 11:17 | Societies

The first day of the 1st Global Summit on War and Cancer: Opening address by the Director-General of the WHO Dr. Tedros Adhanom Ghebreyesus

The first day of the 1st Global Summit on War and Cancer, organized by Institute…

Dec 12, 2023, 03:40 | Dialogues

OncoInfluencers: Dialogue with Dean Crowe, hosted by Gevorg Tamamyan

Join us for an exciting new episode of "OncoInfluencers," hosted by Dr. Gevorg Tamamyan. In…

Dec 10, 2023, 05:08 | Societies

Global Summit on War and Cancer: Agenda

Our Global Summit on War and Cancer brings together experts, researchers, and advocates from around…

Dec 10, 2023, 02:07 | Opinion

Theodore DeWeese: I am honored and humbled to become the next Dean of the Medical Faculty and CEO of Johns Hopkins Medicine

Theodore DeWeese, renowned radiation oncologist, shared on LinkedIn: "I keep this quote from one of…

Dec 9, 2023, 17:55 | Opinion

100 Influential Celebrities in Oncology: The 2023 Edition – Part 6

Continuing OncoDaily's "100 Influential Celebrities in Oncology: The 2023 Edition," we spotlight ten more inspiring…

Dec 9, 2023, 16:52 | Opinion

Lisa A. Lacasse: We are disappointed after hearing this announcement

Lisa A. Lacasse, President at American Cancer Society Cancer Action Network, shared a post on LinkedIn:…

Dec 8, 2023, 17:46 | Drugs

Earle Burgess: Interested in new treatments being developed for advanced (urothelial) bladder cancer?

Earle Burgess, Chief of the Genitourinary Oncology Section at Atrium Health, Levine Cancer Institute, shared…

Dec 6, 2023, 16:05 | Blog

Christine M. Lovly: What does the Board of Directors for a prominent organization such as American Association for Cancer Research discuss at their meetings?

Christine M. Lovly posted on LinkedIn: "What does the Board of Directors for a prominent…

Dec 4, 2023, 16:48 | Dialogues

OncoDaily Dialogues #3 - Andrés Wiernik / Hosted by Roupen Odabashian

We continue our series of “OncoDaily Dialogues”. This effort by OncoDaily focuses on highlighting key…

Dec 2, 2023, 18:08 | Positive

100 Influential Celebrities in Oncology: The 2023 Edition – Part 5

In this latest installment of OncoDaily’s "100 Influential Celebrities in Oncology: The 2023 Edition," we…

Dec 1, 2023, 07:44 | Positive

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to follow on X (Twitter) in 2023

As November, the Lung Cancer Awareness Month, has just concluded, our team at OncoDaily remains…

Nov 30, 2023, 16:18 | Blog

Do you want to be part of the first-ever national cancer innovation accelerator initiative with public support from The White House? - CancerX Moonshot

CancerX Moonshot shared on their LinkedIn page: "Do you want to be part of the…

Nov 30, 2023, 07:24 | Blog

Monica Bertagnolli: It’s one thing to know about cancer as a physician, but it's another to experience it

Quoting Monica Bertagnolli on X/Twitter: “In 2022, I was diagnosed with Breast Cancer. It’s one thing…

Nov 26, 2023, 17:27 | Insight

Marco Donia: Most combinations in oncology have additive but not synergistic efficacy

Marco Donia, Clinical Research Associate Professor at University of Copenhagen, shared on LinkedIn: "Most combinations…

Nov 25, 2023, 17:10 | Positive

100 Influential Celebrities in Oncology: The 2023 Edition – Part 4

For the OncoDaily’s "100 Influential Celebrities in Oncology: The 2023 Edition – Part 4," let's…

Nov 25, 2023, 10:30 | Blog

Tedros Adhanom Ghebreyesus: An estimated 1 million children a year die because of wasting

Tedros Adhanom Ghebreyesus, Director General at the World Health Organization, shared on LinkedIn: "No child…

Nov 24, 2023, 16:23 | Blog

Julie Gralow: Register for ASCO Latin America Regional Council webinar November 30th

Julie Gralow shared a post on LinkedIn: "Register for ASCO Latin America Regional Council webinar…

Nov 23, 2023, 03:19 | Positive

Christine M. Lovly: Such an inspiring day for women in medicine and women in science

Christine M. Lovly posted on LinkedIn: ''Such an inspiring day for women in medicine and women…

Nov 20, 2023, 10:30 | Insight

Steven O'Day: I am thrilled to announce the upcoming launch of “The Immuno-Oncology Curve”

Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I am thrilled to…

Nov 18, 2023, 19:03 | Blog

Tedros Adhanom Ghebreyesus - The current situation is unbearable and unjustifiable. Ceasefire. NOW.

Dr. Tedros Adhanom Ghebreyesus, the Director-General of WHO, shared on X (Twitter): "Today WHO led…

Headlines

OncoDaily

Headlines